Post by
Jon9800 on Jun 15, 2022 12:02pm
The Peer review Articles by Hemostemix
The company has published seven peer reviewed articles about the safety and efficacy of its lead product ACP-01 as a treatment of CLI, PAD, Angina, Ischemic Cardiomyopathy, Dilated Cardiomyopathy and other conditions of ischemia.